Suchergebnisse - "Neurath, Markus F"

PubPharm (1.232)

71

Targeting cytokines in inflammatory bowel disease

enthalten in: Science translational medicine | 2022

von Neurath, M.

72

Motorized spiral enteroscopy : results of an international multicenter prospective observational clinical study in patients with normal and altered gastrointestinal anatomy

enthalten in: Endoscopy | 2022

von Beyna, T. | Moreels, T. | Arvanitakis, M. | +15

CommentIn: Endoscopy. 2022 Dec;54(12):1156-1157. - PMID 35858637

73

PU.1-driven Th9 Cells Promote Colorectal Cancer in Experimental Colitis Models Through Il-6 Effects in Intestinal Epithelial Cells

enthalten in: Journal of Crohn's & colitis | 2022

von Gerlach, K. | Popp, V. | Wirtz, S. | +10

74

Neutrophils prevent rectal bleeding in ulcerative colitis by peptidyl-arginine deiminase-4-dependent immunothrombosis

enthalten in: Gut | 2022

von Leppkes, M. | Lindemann, A. | Gößwein, S. | +22

CommentIn: Gut. 2022 Dec;71(12):2375-2376. - PMID 35074905

75

How the Tumor Micromilieu Modulates the Recruitment and Activation of Colorectal Cancer-Infiltrating Lymphocytes

enthalten in: Biomedicines | 2022

von Atreya, I. | Neurath, M.

76

Surface Design Options in Polymer- and Lipid-Based siRNA Nanoparticles Using Antibodies

enthalten in: International journal of molecular sciences | 2022

von Gabel, M. | Knauss, A. | Fischer, D. | +2

77

Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy

enthalten in: Immunity | 2022

von Denk, D. | Petrocelli, V. | Conche, C. | +13

78

Induction of microRNA-124 as a novel therapeutic concept in ulcerative colitis

enthalten in: The lancet. Gastroenterology & hepatology | 2022

von Atreya, R. | Neurath, M.

CommentOn: Lancet Gastroenterol Hepatol. 2022 Nov;7(11):1024-1035. - PMID 36075249

79

Label-Free Characterization and Quantification of Mucosal Inflammation in Common Murine Colitis Models With Multiphoton Imaging

enthalten in: Inflammatory bowel diseases | 2022

von Thoma, O. | Lemire, S. | Lechner, K. | +14

80

Etrolizumab-s Does Not Induce Residual Trafficking of Regulatory T Cells

enthalten in: Inflammatory bowel diseases | 2022

von Schweda, A. | Becker, E. | Wiendl, M. | +5